Hyounggyoon Yoo

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Topics

Idiopathic Pulmonary Fibrosis

Postmenopausal Women

Top Venues

Expert opinion on biological therapy

Translational and clinical pharmacology

Clinical and translational science

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Wonsuk Shin, Min Young Park, Jongwoo Kim, Jihyeon Kim, Jun Hee Nam, Jongwon Choi, A-Young Yang, Hyounggyoon Yoo, Yil-Seob Lee, Anhye Kim
No drug-drug interactions between selective prolyl-tRNA synthetase inhibitor, bersiporocin, and pirfenidone or nintedanib in healthy participants. Clinical and translational science 17 (1) (2024)
Anhye Kim, Jang Hee Hong, Wonsuk Shin, Hyounggyoon Yoo, Jin Gyu Jung, Jean-Yves Reginster, SungHyun Kim, YunJu Bae, JeeHye Suh, Sera Kim, EunKyung Lee, Stuart L Silverman
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males. Expert opinion on biological therapy (2024)
Wonsuk Shin, Min Young Park, Jongwoo Kim, Jihyeon Kim, Jun Hee Nam, Jongwon Choi, A-Young Yang, Hyounggyoon Yoo, Yil-Seob Lee, Anhye Kim
No drug-drug interactions between selective prolyl-tRNA synthetase inhibitor, bersiporocin, and pirfenidone or nintedanib in healthy participants. Clinical and translational science 17 (1) (2024)
Anhye Kim, Jang-Hee Hong, Wonsuk Shin, Hyounggyoon Yoo, Jin Gyu Jung, Jean-Yves Reginster, SungHyun Kim, YunJu Bae, JeeHye Suh, Sera Kim, EunKyung Lee, Stuart L Silverman
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males. Expert opinion on biological therapy 24 (7) (2024)
Anhye Kim, Jang-Hee Hong, Wonsuk Shin, Hyounggyoon Yoo, Jin Gyu Jung, Jean-Yves Reginster, SungHyun Kim, YunJu Bae, JeeHye Suh, Sera Kim, EunKyung Lee, Stuart L Silverman
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males. Expert opinion on biological therapy (2024)
Anhye Kim, Jang-Hee Hong, Wonsuk Shin, Hyounggyoon Yoo, Jin Gyu Jung, Jean-Yves Reginster, SungHyun Kim, YunJu Bae, JeeHye Suh, Sera Kim, EunKyung Lee, Stuart L Silverman
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males. Expert opinion on biological therapy 24 (7) (2024)
Anhye Kim, Jang-Hee Hong, Wonsuk Shin, Hyounggyoon Yoo, Jin Gyu Jung, Jean-Yves Reginster, SungHyun Kim, YunJu Bae, JeeHye Suh, Sera Kim, EunKyung Lee, Stuart L Silverman
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males. Expert opinion on biological therapy (2024)
Anhye Kim, Jang-Hee Hong, Wonsuk Shin, Hyounggyoon Yoo, Jin Gyu Jung, Jean-Yves Reginster, SungHyun Kim, YunJu Bae, JeeHye Suh, Sera Kim, EunKyung Lee, Stuart L Silverman
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males. Expert opinion on biological therapy 24 (7) (2024)
Maria Park, Suein Choi, Sungpil Han, Wonsuk Shin, Anhye Kim, Seunghoon Han, Bomin Kim, Yeji Lim, Hyounggyoon Yoo
Pharmacokinetic properties of a new sustained-release pregabalin tablet in subjects with reduced renal function. Translational and clinical pharmacology 31 (4) (2023)
A-Young Yang, Hyounggyoon Yoo, Wonsuk Shin, Yil-Seob Lee, Hyejung Lee, Sung-Eun Kim, Anhye Kim
Size-reduced fexuprazan 20 mg demonstrated the optimal bioavailability and bioequivalence with the reference formulation. Translational and clinical pharmacology 31 (1) (2023)
Maria Park, Suein Choi, Sungpil Han, Wonsuk Shin, Anhye Kim, Seunghoon Han, Bomin Kim, Yeji Lim, Hyounggyoon Yoo
Pharmacokinetic properties of a new sustained-release pregabalin tablet in subjects with reduced renal function. Translational and clinical pharmacology 31 (4) (2023)
Joo Young Na, Deok Yong Yoon, Hyounggyoon Yoo, Seung Hwan Lee, Kyung-Sang Yu, In-Jin Jang, Sang-Ku Yoo, Youngah Kim, Jaeseong Oh
Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first-in-class, first-in-human study. Clinical and translational science 15 (11) (2022)
Ki Young Huh, Sae Im Jeong, Hyounggyoon Yoo, Meihua Piao, Hyeongju Ryu, Heejin Kim, Young-Ran Yoon, Sook Jin Seong, Seung Hwan Lee, Kyung-Hwan Kim
Lessons from a multicenter clinical trial with an approved wearable electrocardiogram: issues and practical considerations. Translational and clinical pharmacology 30 (2) (2022)
Soonok Sa, Chae Won Lee, Sung Ryul Shim, Hyounggyoon Yoo, Jinwha Choi, Ju Hee Kim, Kiwon Lee, Myunghee Hong, Hyun Wook Han
The Safety of mRNA-1273, BNT162b2 and JNJ-78436735 COVID-19 Vaccines: Safety Monitoring for Adverse Events Using Real-World Data. Vaccines 10 (2) (2022)
Eunsol Yang, Hyounggyoon Yoo, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study. Drug design, development and therapy 15 (2021)
Inyoung Hwang, Yun Kim, Hyounggyoon Yoo, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects. Drug design, development and therapy 14 (2020)
Hyounggyoon Yoo, Yun Kim, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects. Drug design, development and therapy 14 (2020)